Development of specific adsorbents for human tumor necrosis factor-α: Influence of antibody immunobilization on performance and biocompatibility

Biomacromolecules

Volumn 6, Issue 4, 2005, Pages 1864-1870

  Weber, Viktoria ^a   Linsberger, Ingrid ^a   Ettenauer, Marion ^a   Loth, Fritz ^b   Höyhtyä, Matti ^c   Falkenhagen, Dieter ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b FRAUNHOFER INSTITUTE FOR APPLIED POLYMER RESEARCH   (Germany)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORBENTS; BINDING ENERGY; BLOOD; CHELATION; CHEMICAL ACTIVATION; MONOCLONAL ANTIBODIES; PURIFICATION;

ADSORPTION CAPACITY; BINDING CAPACITY; HUMAN PLASMA; MICROPARTICLES;

TUMORS;

ADSORBENT; CELLULOSE; CHELATE; COMPLEMENT; HISTIDINE; MONOCLONAL ANTIBODY; PERIODATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADSORPTION KINETICS; APHERESIS; ARTICLE; BATCH PROCESS; BIOCOMPATIBILITY; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; HUMAN; IN VITRO STUDY; LEACHING; PARTICLE SIZE; PH; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN IMMOBILIZATION; TASK PERFORMANCE; TEMPERATURE;

ADSORPTION; ANTIBODIES; BIOCOMPATIBLE MATERIALS; CELLULOSE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MICROSCOPY, ELECTRON; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22944466418     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm040074t     Document Type: Article

References (25)

1. Peluso P.; Wilson, D. S.; Do, D.; Traan, H.; Venkatasubbaiah, M.; Quincy, D.; Heidecker, B.; Poindexter, K.; Tolani, N.; Phelan, M.; Witte, K.; Jung, L. S.; Wagner, P.; Nock, S. Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal. Biochem. 2003, 312, 113-124.
2. Vanková, R.; Gaudinová, A.. Süssenbeková, H.; Dobrev, P.; Strnad, M.; Holík, J.; Lenfeld, J. Comparison of oriented and random antibody immobilization in immunoaffinity chromatography of cytokinins. J. Chromatogr. A 1998, 811, 77-84.
3. Lu, B.; Smyth M. R., O'Kennedy, R. Oriented immobilization of antibodies and its applications in immunoassays and immunosensors. Analyst 1996, 121, 29R-32R.
4. Reimer, U.; Reineke, U.; Schneider-Mergener, J. Peptide arrays: from macro to micro. Curr. Opin. Biotechnol. 2002, 13, 315-320.
5. Danczyk, R.; Krieder, B.; North, A.; Webster, T.; HogenEsch, H.; Rundell, A. Comparison of antibody functionality rising different immobilization methods. Biotechnol. Bioeng. 2003, 84 (2), 215-223.
6. Brogan, K. L.; Wolfe, K. N.; Jones, P. A.; Schoenfisch, M. direct oriented immobilization of F(ab') antibody fragments on gold. Anal. Chim. Acta, 2003, 496, 73-80.
7. Wimalasena, R. L.; Wilson, G. S. Factors affecting the specific activity of immobilized antibodies and their biologically active fragments. J. Chromatogr. 1991, 572, 85-102.
8. Subramanian, A.; Velander, W. H. Effect of antibody orientation on immunosorbent performance. J. Mol. Recognit. 1996, 9, 528-535.
9. Turková, J. Oriented immobilization of biologically active proteins as a tool for revealing protein interactions and function. J. Chromatogr. B 1999, 722, 11-31.
10. Wilchek, M.; Miropn, T. Oriented versus random protein immobilization. J. Biochem. Biophys. Methods 2003, 55, 67-70.
11. Reference deleted in revision.
12. Hoogenboom, H. R. Overview of antibody phage-display technology and its applications. Methods Mol. Biol. 2002, 178, 1-37.
13. Falkenhagen, D. Schima, H.; Loth, F. Arrangement for removing substances from liquids, in particular blood. United States Patent, # 5,855,782, 1999.
14. von Appen, K.; Weber, C.; Losert, U.; Schima, H.; Gurland, H. J.; Falkenhagen, D. Microspheres based detoxification system: a new method in convective blood purification. Artif. Organs. 1996, 20, 420-425.
15. Völlenkle, C., Weigert, S.; Ilk, N.; Egelseer, E.; Weber, V.; Loth, F.; Falkenhagen, D.; Sleytr, U. B.; Sára M. Construction of a functional S-layer fusion protein comprising an immunoglobulin G-binding domain for development of specific adsorbents for extracorporeal blood purification. Appl. Environ. Microbiol. 2004, 1514-1521.
16. Fiers, W. Tumor necrosis factor. Characterization at the molecular, cellular, and in vivo level. FEBS Lett. 1991, 285, 199-212.
17. Tracey, K. J.; Cerami, A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 1994, 45, 491-503.
18. Johnson R. J. Complement activation during extracorporeal therapy: biochemistry, cell biology and clinical relevance. Nephrol. Dial. Transplant. 1994, 9, 36-45.
19. Pessela, B. C. C.; Mateo, C.; Carrascosa, A. V.; Vian, A.; García J. L.; Rivas, G.; Alfonso, C.; Guisan, J. M.; Fernández-Lafuente, R. One-Step Purification, Covalent Immobilization, and Additional Stabilization of a Thermophilic Poly-his-Tagged β-Galactosidase from Thermus sp. Strain T2 by using Novel Heterofunctional Chelate-Epoxy Sepabeads. Biomacromolecules 2003, 4, 107-113.
20. Knight, D. M.; Trinh, H.; Le, J.; Siegel, S.; Shealy, D., McConough, M.; Scallon, B.; Moore, M. A.; Vilcek, J.; Daddona, P.; Ghrayeb, J. Construction and initial characterization of a mouse-human chimeric anti-TNFantibody. Mol. Immunol. 1993, 30, 1443-1453.
21. Targan, S. R.; Hanauer, S. B.; van Deventer, S. J.; Mayer, L.; Present, D. H.; Braakman, T.; DeWoody, K. L.; Schaible, T. F.; Rutgeerts, P. J. A short-term study of the chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N. Engl. J. Med. 1997, 337 (15), 1029-1035.
22. Klinkhoff, A. Biological agents for rheumatoid arthritis: targeting both physical function and structural damage. Drugs 2004, 64, 1267-83.
23. Olsen, N. J.; Stein, C. M. New drugs for rheumatoid arthritis. N. Engl. J. Med. 2004, 350 (21), 2167-79.
24. Peng, L.; Calton, G. J.; Burnett, J. W. Effect of borohydride reduction on antibodies. Appl. Biochem. Biotechnol. 1987, 14, 91-99.
25. Hirata, I.; Hioki, J.; Toda, M.; Kirazawa, T.; Murakami, Y.; Kitano, E.; Kitamura, H.; Ikada, Y.; Iwata, H. Deposition of complement protein C3b on mixed self-assembled monolayers carrying surface hydroxyl and methyl groups studied by surface plasmon resonance. J. Biomed. Mater. Res. 2003, 66A, 669-676.